Comparison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis
Nigel Brown, Jane A. May, Robert G. Wilcox, Linda M. Allan, Adrian M. Wilson, Peter S. Kiff, Stan HeptinstallVolume:
48
Year:
1999
Language:
english
Pages:
6
DOI:
10.1046/j.1365-2125.1999.00947.x
File:
PDF, 96 KB
english, 1999